Quick Answer
GoodRx Holdings, Inc. reported Operating Income of $87.49 million for fiscal year 2025.
GoodRx Holdings, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $87.49M | +32.9% |
| 2024 | $65.85M | +343.8% |
| 2023 | -$27.01M | -1653.9% |
| 2022 | $1.74M | -87.0% |
| 2021 | $13.41M | +104.9% |
| 2020 | -$275.72M | -297.4% |
| 2019 | $139.68M | +80.8% |
| 2018 | $77.25M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.62M | -28.4% | -45.5% |
| June 30, 2025 | $26.81M | +34.9% | +14.7% |
| March 31, 2025 | $23.38M | +216.8% | +14.6% |
| September 30, 2024 | $20.41M | +153.2% | +2.7% |
| June 30, 2024 | $19.88M | +8.6% | +169.3% |
| March 31, 2024 | $7.38M | -34.7% | +119.3% |
| September 30, 2023 | -$38.33M | -143.9% | -309.4% |
| June 30, 2023 | $18.31M | +552.4% | +62.0% |
- GoodRx Holdings, Inc. showed an increase of +32.9% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, GoodRx Holdings, Inc.’s operating income has grown by 13.3% (from $77.25 million to $87.49 million).
- The most recent figure is from GoodRx Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: